Security key
98420N105
Xenon Pharmaceuticals Inc. - Common Shares (XENE)
CUSIP: 98420N105
Q3 2018 13F Holders as of 30 Sep 2018
- Security type / class
- Equity / Common Shares
- Total 13F shares
- 17,678,662
- Total 13F value
- $234,229,778
- Share change
- +8,575,181
- SEC-reported price per share
- $13.20
- Number of holders
- 59
- Value change
- +$115,388,474
- Number of buys
- 36
- Number of sells
- 22
- Shares outstanding
- 92,799,600
Holder snapshot
6 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q3 2018
Institutions
59
Top holders
10
XENE full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q2 2026
Xenon Pharmaceuticals Inc. SEC filings
Xenon Pharmaceuticals Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 98420N105
Recent filing periods:
Ownership snapshot
Top reported holders of XENE - Xenon Pharmaceuticals Inc. - Common Shares (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Capital World Investors
Disclosed value leader
Capital World Investors
Comparable rows
15/15
Latest evidence
30 Jun 2018
13F
Lead comparable stake: 1.5%
Showing 1-6 of 15 holder rows.
Quick read
Capital World Investors leads the comparable SEC ownership view at 1.5%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Capital World Investors's linked filing trail.
Comparable ownership
Top 5
Capital World Investors
1.5%
Avoro Capital Advisors LLC
1.3%
ADAGE CAPITAL PARTNERS GP, L.L.C.
0.86%
BVF INC/IL
0.78%
ORBIMED ADVISORS LLC
0.68%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Capital World Investors |
13F
Company
|
1.5%
|
$13,147,000
1,429,000 shares
|
— | 30 Jun 2018 |
| Avoro Capital Advisors LLC |
13F
Company
|
1.3%
|
$11,059,000
1,202,118 shares
|
— | 30 Jun 2018 |
| ADAGE CAPITAL PARTNERS GP, L.L.C. |
13F
Company
|
0.86%
|
$7,360,000
800,000 shares
|
— | 30 Jun 2018 |
| BVF INC/IL |
13F
Company
|
0.78%
|
$6,632,000
720,830 shares
|
— | 30 Jun 2018 |
| ORBIMED ADVISORS LLC |
13F
Company
|
0.68%
|
$5,840,000
634,812 shares
|
— | 30 Jun 2018 |
| RENAISSANCE TECHNOLOGIES LLC |
13F
Company
|
0.53%
|
$4,503,000
489,500 shares
|
— | 30 Jun 2018 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q3 2018
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
59
Shares
17,678,662
Rows available
59
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q3 2018 vs Q2 2018 Across Filers
Q2 2018 holders
41
Q3 2018 holders
59
Holder diff
18
| Investor | Q2 2018 Shares | Q3 2018 Shares | Share Diff | Share Chg % | Q2 2018 value | Q3 2018 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend